Literature DB >> 10208737

Neuronal damage produced in rat brains by Clostridium perfringens type D epsilon toxin.

J W Finnie1, P C Blumbergs, J Manavis.   

Abstract

This paper reports neuronal changes in rat brains subacutely intoxicated with Copyright Clostridium perfringens type D epsilon toxin. Neuronal damage was characterized by either (1) progressive cytoplasmic vacuolation leading to necrosis, or (2) shrunken hyperchromatic cells with nuclear pyknosis. The neuronal injury was also often bilaterally symmetrical, particularly in the brainstem. These findings suggest that, after gaining access to brain tissue by producing an increase in vascular permeability, epsilon toxin later exerts a directly cytotoxic effect on neurons. 1999 W.B. Saunders and Company Ltd.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10208737     DOI: 10.1053/jcpa.1998.0289

Source DB:  PubMed          Journal:  J Comp Pathol        ISSN: 0021-9975            Impact factor:   1.311


  23 in total

1.  Accumulation of Clostridium perfringens epsilon-toxin in the mouse kidney and its possible biological significance.

Authors:  Eiji Tamai; Tetsuya Ishida; Shigeru Miyata; Osamu Matsushita; Hirofumi Suda; Shoji Kobayashi; Hiroshi Sonobe; Akinobu Okabe
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

2.  Clostridium perfringens epsilon-toxin increases permeability of single perfused microvessels of rat mesentery.

Authors:  R H Adamson; J C Ly; M Fernandez-Miyakawa; S Ochi; J Sakurai; F Uzal; F E Curry
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

Review 3.  Comparative pathogenesis of enteric clostridial infections in humans and animals.

Authors:  Francisco A Uzal; Mauricio A Navarro; Jihong Li; John C Freedman; Archana Shrestha; Bruce A McClane
Journal:  Anaerobe       Date:  2018-06-05       Impact factor: 3.331

4.  The Cytotoxicity of Epsilon Toxin from Clostridium perfringens on Lymphocytes Is Mediated by MAL Protein Expression.

Authors:  Marta Blanch; Jonatan Dorca-Arévalo; Anna Not; Mercè Cases; Inmaculada Gómez de Aranda; Antonio Martínez-Yélamos; Sergio Martínez-Yélamos; Carles Solsona; Juan Blasi
Journal:  Mol Cell Biol       Date:  2018-09-14       Impact factor: 4.272

Review 5.  The microbiome in autoimmune diseases.

Authors:  F De Luca; Y Shoenfeld
Journal:  Clin Exp Immunol       Date:  2019-01       Impact factor: 4.330

6.  Prevention and treatment of Clostridium perfringens epsilon toxin intoxication in mice with a neutralizing monoclonal antibody (c4D7) produced in Nicotiana benthamiana.

Authors:  J P Garcia; J Beingesser; O Bohorov; N Bohorova; C Goodman; D Kim; M Pauly; J Velasco; K Whaley; L Zeitlin; C J Roy; F A Uzal
Journal:  Toxicon       Date:  2014-06-17       Impact factor: 3.033

7.  Clostridium perfringens epsilon toxin targets granule cells in the mouse cerebellum and stimulates glutamate release.

Authors:  Etienne Lonchamp; Jean-Luc Dupont; Laetitia Wioland; Raphaël Courjaret; Corinne Mbebi-Liegeois; Emmanuel Jover; Frédéric Doussau; Michel R Popoff; Jean-Louis Bossu; Jean de Barry; Bernard Poulain
Journal:  PLoS One       Date:  2010-09-30       Impact factor: 3.240

Review 8.  Gut microbiome and multiple sclerosis.

Authors:  Pavan Bhargava; Ellen M Mowry
Journal:  Curr Neurol Neurosci Rep       Date:  2014-10       Impact factor: 5.081

9.  Epsilon toxin is essential for the virulence of Clostridium perfringens type D infection in sheep, goats, and mice.

Authors:  J P Garcia; V Adams; J Beingesser; M L Hughes; R Poon; D Lyras; A Hill; B A McClane; J I Rood; F A Uzal
Journal:  Infect Immun       Date:  2013-04-29       Impact factor: 3.441

Review 10.  Pathogenesis and diagnostic features of brain and ophthalmic damage produced by Clostridium perfringens type D epsilon toxin.

Authors:  John W Finnie; Mauricio A Navarro; Francisco A Uzal
Journal:  J Vet Diagn Invest       Date:  2020-01-20       Impact factor: 1.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.